Biotricity Statistics
Total Valuation
Biotricity has a market cap or net worth of $16.33 million. The enterprise value is $39.42 million.
| Market Cap | 16.33M |
| Enterprise Value | 39.42M |
Important Dates
The last earnings date was Thursday, June 27, 2024, before market open.
| Earnings Date | Jun 27, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Biotricity has 21.48 million shares outstanding. The number of shares has increased by 3.83% in one year.
| Shares Outstanding | 21.48M |
| Shares Change (YoY) | +3.83% |
| Shares Change (QoQ) | +5.11% |
| Owned by Insiders (%) | 48.62% |
| Owned by Institutions (%) | 1.66% |
| Float | 19.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.35 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.27 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.20
| Current Ratio | 0.20 |
| Quick Ratio | 0.11 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.67 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -244.80% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $219,334 |
| Profits Per Employee | -$271,436 |
| Employee Count | 55 |
| Asset Turnover | 1.98 |
| Inventory Turnover | 1.76 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -76.76% in the last 52 weeks. The beta is 1.41, so Biotricity's price volatility has been higher than the market average.
| Beta (5Y) | 1.41 |
| 52-Week Price Change | -76.76% |
| 50-Day Moving Average | 1.10 |
| 200-Day Moving Average | 1.24 |
| Relative Strength Index (RSI) | 31.78 |
| Average Volume (20 Days) | 49,995 |
Short Selling Information
The latest short interest is 503,012, so 2.34% of the outstanding shares have been sold short.
| Short Interest | 503,012 |
| Short Previous Month | 618,404 |
| Short % of Shares Out | 2.34% |
| Short % of Float | 2.58% |
| Short Ratio (days to cover) | 7.94 |
Income Statement
In the last 12 months, Biotricity had revenue of $12.06 million and -$14.93 million in losses. Loss per share was -$1.66.
| Revenue | 12.06M |
| Gross Profit | 8.36M |
| Operating Income | -8.83M |
| Pretax Income | -14.09M |
| Net Income | -14.93M |
| EBITDA | -10.70M |
| EBIT | -11.08M |
| Loss Per Share | -$1.66 |
Balance Sheet
The company has $786,060 in cash and $23.88 million in debt, giving a net cash position of -$23.09 million or -$1.07 per share.
| Cash & Cash Equivalents | 786,060 |
| Total Debt | 23.88M |
| Net Cash | -23.09M |
| Net Cash Per Share | -$1.07 |
| Equity (Book Value) | -31.47M |
| Book Value Per Share | -1.46 |
| Working Capital | -18.23M |
Cash Flow
| Operating Cash Flow | -6.69M |
| Capital Expenditures | n/a |
| Free Cash Flow | -6.69M |
| FCF Per Share | -$0.74 |
Margins
Gross margin is 69.27%, with operating and profit margins of -73.18% and -123.75%.
| Gross Margin | 69.27% |
| Operating Margin | -73.18% |
| Pretax Margin | -116.84% |
| Profit Margin | -123.75% |
| EBITDA Margin | -88.73% |
| EBIT Margin | -91.81% |
| FCF Margin | -55.49% |
Dividends & Yields
Biotricity does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.83% |
| Shareholder Yield | -3.83% |
| Earnings Yield | -91.43% |
| FCF Yield | -41.00% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 3, 2023. It was a reverse split with a ratio of 1:6.
| Last Split Date | Jul 3, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:6 |
Scores
Biotricity has an Altman Z-Score of -37.57 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -37.57 |
| Piotroski F-Score | 4 |